FOLD
Amicus Therapeutics Inc
Price:  
13.46 
USD
Volume:  
1,528,811.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FOLD EV/EBITDA

-137.2%
Upside

As of 2024-03-05, the EV/EBITDA ratio of Amicus Therapeutics Inc (FOLD) is -48.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FOLD's latest enterprise value is 4,088.01 mil USD. FOLD's TTM EBITDA according to its financial statements is -84.00 mil USD. Dividing these 2 quantities gives us the above FOLD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.9x - 18.9x 13.9x
Forward P/E multiples 16.7x - 21.9x 17.7x
Fair Price (5.28) - (5.88) (5.01)
Upside -139.2% - -143.7% -137.2%
13.46 USD
Stock Price
(5.01) USD
Fair Price

FOLD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-04 -48.67
2024-03-01 -48.07
2024-02-29 -46.43
2024-02-28 -46.89
2024-02-27 -50.03
2024-02-26 -49.78
2024-02-23 -48.91
2024-02-22 -48.46
2024-02-21 -49.02
2024-02-20 -49.51
2024-02-16 -49.71
2024-02-15 -50.55
2024-02-14 -47.69
2024-02-13 -46.36
2024-02-12 -49.75
2024-02-09 -48.98
2024-02-08 -48.21
2024-02-07 -47.06
2024-02-06 -46.99
2024-02-05 -46.01
2024-02-02 -45.11
2024-02-01 -45.91
2024-01-31 -45.07
2024-01-30 -45.84
2024-01-29 -46.96
2024-01-26 -44.76
2024-01-25 -45.80
2024-01-24 -45.56
2024-01-23 -45.18
2024-01-22 -45.07
2024-01-19 -43.68
2024-01-18 -45.04
2024-01-17 -46.50
2024-01-16 -46.08
2024-01-12 -47.69
2024-01-11 -48.28
2024-01-10 -49.05
2024-01-09 -49.33
2024-01-08 -50.76
2024-01-05 -48.88
2024-01-04 -48.60
2024-01-03 -48.91
2024-01-02 -51.39
2023-12-29 -51.22
2023-12-28 -52.37
2023-12-27 -52.05
2023-12-26 -50.87
2023-12-22 -49.16
2023-12-21 -47.62
2023-12-20 -46.50